Optymous - Specialized Social Listening for EU Pharma Companies

Challenges of Modern Pharma in the Digital Age

Generic social listening tools weren't built for pharma.
Here's why.

Specific Market Understanding

Track patient sentiment and HCP engagement across complex channels

Understanding patient sentiment and HCP engagement across diverse European markets presents unique challenges. Each region has distinct healthcare systems, prescribing patterns, and patient behaviors. Traditional social listening tools fail to capture these nuances, leading to missed opportunities and misaligned strategies. Companies need specialized capabilities to track conversations across languages, platforms, and healthcare contexts.

Multi-language Safety Monitoring

Real-time adverse event detection across languages

Adverse event detection in social media requires sophisticated technology that can identify potential safety signals in multiple languages and contexts. Manual monitoring is time-consuming and error-prone, while generic tools miss critical mentions. Companies need real-time alerting that can distinguish between casual complaints and genuine safety concerns, while ensuring all regulatory reporting requirements are met.

Complex Regulations

Navigate EU-specific healthcare compliance requirements

European pharmaceutical companies face increasingly strict regulatory requirements around social media monitoring. From GDPR compliance to EMA guidelines on adverse event reporting, maintaining compliance while gathering meaningful insights is complex. Companies need a solution that automatically identifies and flags regulatory concerns while providing actionable intelligence across multiple jurisdictions.

Specialised social listening